A Workflow of Integrated Resources to Catalyze Network Pharmacology Driven COVID-19 Research
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
No abstract available
Article activity feed
-
-
SciScore for 10.1101/2020.11.04.369041: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
NIH rigor criteria are not applicable to paper type.Table 2: Resources
Software and Algorithms Sentences Resources Furthermore, the DrugCentral database also provides information on DTIs; 15,397 human DTIs and 4,910 nonhuman DTIs; of these 2,752 (2,328 human) are MoA drug-target associations. DrugCentralsuggested: (DrugCentral, RRID:SCR_015663)The DTIs were originally extracted from scientific literature, drug labels and other data sources such as, ChEMBL [4], IUPHAR Guide2Pharmacology [59], WOMBAT-PK [ ChEMBLsuggested: (ChEMBL, RRID:SCR_014042)60], DrugBank [61] and KEGG Drug [62]. DrugBanksuggested: (DrugBank, RRID:SCR_002700)KEGGsuggested: (KEGG, RRID:SCR_012773)Results from OddPub: Thank you for …
SciScore for 10.1101/2020.11.04.369041: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
NIH rigor criteria are not applicable to paper type.Table 2: Resources
Software and Algorithms Sentences Resources Furthermore, the DrugCentral database also provides information on DTIs; 15,397 human DTIs and 4,910 nonhuman DTIs; of these 2,752 (2,328 human) are MoA drug-target associations. DrugCentralsuggested: (DrugCentral, RRID:SCR_015663)The DTIs were originally extracted from scientific literature, drug labels and other data sources such as, ChEMBL [4], IUPHAR Guide2Pharmacology [59], WOMBAT-PK [ ChEMBLsuggested: (ChEMBL, RRID:SCR_014042)60], DrugBank [61] and KEGG Drug [62]. DrugBanksuggested: (DrugBank, RRID:SCR_002700)KEGGsuggested: (KEGG, RRID:SCR_012773)Results from OddPub: Thank you for sharing your code and data.
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-